Paradigm Biopharmaceuticals | PAR - Operating Expenses

Stock Price
0.30
Daily Change
-0.02 -4.76%
Monthly
-18.92%
Yearly
-44.95%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD8.49M in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Avita Medical AUD 29.57M 1.21M Jun/2025
Medical Developments International AUD 10.02M 9.78M Jun/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025
Pacific Edge NZD 25.34M 2.03M Dec/2025
PYC Therapeutics AUD 19.3M 19.28M Jun/2025
Telix Pharmaceuticals AUD 191.9M 130.08M Dec/2024